We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
Cap. Flow
+$3.02B
Cap. Flow %
5.11%
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$905M
2
NVDA icon
NVIDIA
NVDA
+$592M
3
AMD icon
Advanced Micro Devices
AMD
+$439M
4
AMGN icon
Amgen
AMGN
+$385M
5
ADBE icon
Adobe
ADBE
+$382M

Sector Composition

Rank Sector Weight
1 Technology 14.79%
2 Consumer Discretionary 13.23%
3 Healthcare 12.61%
4 Financials 7.44%
5 Communication Services 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
76
Oracle
ORCL
$331B
$137M 0.23%
1,301,307
-1,447,605
-53% -$158M
NU icon
77
Nu Holdings
NU
$68.1B
$136M 0.23%
16,371,595
+850,128
+5% +$6.87M
SHW icon
78
Sherwin-Williams
SHW
$78.3B
$135M 0.23%
+431,818
New +$116M
AAPL icon
79
PUT
Apple
AAPL
$4.89T
$135M 0.23%
699,100
+632,500
+950% +$117M
IWM icon
80
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$134M 0.23%
666,600
+507,500
+319% +$90.9M
MMM icon
81
3M
MMM
$89B
$133M 0.22%
1,450,056
+833,431
+135% +$66.9M
WING icon
82
Wingstop
WING
$3.68B
$132M 0.22%
515,420
+97,530
+23% +$21.1M
AAPL icon
83
CALL
Apple
AAPL
$4.89T
$132M 0.22%
683,300
+648,900
+1,886% +$120M
OPCH icon
84
Option Care Health
OPCH
$3.4B
$131M 0.22%
3,880,397
+1,401,123
+57% +$43.1M
UNH icon
85
UnitedHealth
UNH
$382B
$131M 0.22%
248,158
-14,129
-5% -$7.54M
PG icon
86
Procter & Gamble
PG
$343B
$129M 0.22%
880,053
+280,980
+47% +$41.6M
BAC icon
87
Bank of America
BAC
$435B
$128M 0.22%
3,792,535
-8,647,145
-70% -$252M
SPY icon
88
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$128M 0.22%
268,500
-92,100
-26% -$41M
ANF icon
89
Abercrombie & Fitch
ANF
$4.17B
$127M 0.22%
1,444,198
-913,615
-39% -$65M
PSA icon
90
Public Storage
PSA
$60.2B
$126M 0.21%
413,636
+403,337
+3,916% +$107M
CC icon
91
Chemours
CC
$2.59B
$123M 0.21%
3,912,010
+2,430,821
+164% +$66M
VAL icon
92
Valaris
VAL
$5.51B
$123M 0.21%
1,799,371
+682,683
+61% +$46.8M
MELI icon
93
Mercado Libre
MELI
$91.3B
$122M 0.21%
77,614
-68,058
-47% -$96.5M
FISV
94
Fiserv Inc
FISV
$27.2B
$121M 0.21%
912,345
+827,515
+975% +$102M
RACE icon
95
Ferrari
RACE
$63.3B
$116M 0.2%
345,009
-92,539
-21% -$30.9M
TROW icon
96
T. Rowe Price
TROW
$25B
$115M 0.2%
1,071,379
+751,216
+235% +$74.8M
SNPS icon
97
Synopsys
SNPS
$71.5B
$115M 0.19%
223,229
+142,229
+176% +$72.7M
TJX icon
98
TJX Companies
TJX
$170B
$114M 0.19%
1,210,211
+531,760
+78% +$47.7M
VRTX icon
99
Vertex Pharmaceuticals
VRTX
$121B
$113M 0.19%
278,330
+72,715
+35% +$26.9M
COO icon
100
Cooper Companies
COO
$13.7B
$113M 0.19%
+1,195,168
New +$100M

Similar funds

Marshall Wace's Q4 2023 Portfolio in Review

As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.

  • Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
  • Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
  • Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
  • Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
  • Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.

Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.